Rajostat Pharmaceuticlas Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 12.38%
- Profit Growth 20.11%
- Ebitda 106.25%
- Net Worth 1.27%
- Total Assets 4.12%
About Rajostat Pharmaceuticlas
Rajostat Pharmaceuticlas Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 July 2007 and has a history of 17 years and six months. Its registered office is in Raipur, Chattisgarh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Pushpa Kochar and Pankaj Jain serve as directors at the Company.
Company Details
-
Location
Raipur, Chattisgarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232CT2007PTC020330
-
Company No.
020330
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Jul 2007
-
Date of AGM
27 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Chhattisgarh
Industry
Who are the key members and board of directors at Rajostat Pharmaceuticlas?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pushpa Kochar
|
Director | 31-Jul-2007 | Current |
|
Pankaj Jain
|
Director | 03-Aug-2018 | Current |
Financial Performance of Rajostat Pharmaceuticlas.
Rajostat Pharmaceuticlas Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 12.38% increase. The company also saw a substantial improvement in profitability, with a 20.11% increase in profit. The company's net worth moved up by a moderate rise of 1.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rajostat Pharmaceuticlas?
In 2017, Rajostat Pharmaceuticlas had a promoter holding of 40.00% and a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Eric Global Energy LimitedPankaj Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rajostat Pharmaceuticlas?
Unlock and access historical data on people associated with Rajostat Pharmaceuticlas, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajostat Pharmaceuticlas, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajostat Pharmaceuticlas's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
